Active Ingredient(s): Pegfilgrastim
FDA Approved: * January 31, 2002
Pharm Company: * AMGEN
Category: Cancer

Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.[5] It serves to stimulate the production of white blood cells (neutrophils).[5][7] Pegfilgrastim was developed by Amgen.[8] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Neulasta 6 mg/.6ml Subcutaneous Injection
NDC: 54868-5229
Physicians Total Care, Inc.
Neulasta 6 mg/.6ml Subcutaneous Injection
NDC: 55513-190
Amgen Inc
Neulasta Subcutaneous Kit
NDC: 55513-192
Amgen Inc

Related Brands

Drugs with the same active ingredients

Popular Topics

Neulasta Side Effects

What side effects have others encountered while taking Neulasta? ## I don't have any personal experience with this m...